Načítá se...
Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of the Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop
Pancreatic cancer is the fourth leading cause of cancer death in the United States and the five-year relative survival for patients diagnosed with pancreatic cancer is less than 10%. Early intervention is the key to a better survival outcome. Currently, there are no biomarkers that can reliably dete...
Uloženo v:
| Vydáno v: | Pancreas |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777224/ https://ncbi.nlm.nih.gov/pubmed/29346214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000973 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|